Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells

Biochem Biophys Res Commun. 2000 Jan 27;267(3):960-3. doi: 10.1006/bbrc.1999.2064.

Abstract

Interleukin-18 (IL-18) binding protein is a soluble decoy receptor for IL-18 which efficiently antagonizes biological functions of IL-18 in vitro and in vivo. Since regulation of IL-18 activity likely contributes to the pathogenesis of inflammatory diseases as well as malignancies, we investigated gene expression of IL-18 binding protein (IL-18BP) in different human cell systems, namely in the keratinocyte cell line HaCaT, in the colon carcinoma cell line DLD-1, and in primary renal mesangial cells. In unstimulated cells only minute amounts of mRNA coding for IL-18 binding protein were detectable. However, in all three cell types gene expression was markedly upregulated by interferon-gamma (IFN-gamma). IL-18 is recognized as a pivotal mediator of IFN-gamma production. Therefore, the present data imply that activity of IL-18 is modulated by a negative feedback mechanism which is mediated by IFN-gamma-induced IL-18 binding protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cells, Cultured
  • Colonic Neoplasms
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Glomerular Mesangium / cytology
  • Glomerular Mesangium / drug effects
  • Glomerular Mesangium / physiology
  • Glycoproteins / genetics*
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Interferon-gamma / pharmacology*
  • Interleukin-1 / pharmacology
  • Interleukin-18 / genetics
  • Keratinocytes
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / physiology*
  • Tumor Cells, Cultured

Substances

  • Glycoproteins
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1
  • Interleukin-18
  • interleukin-18 binding protein
  • Interferon-gamma